Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PCD”

625 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 625 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Not applicableStudy completedNCT04502849
What this trial is testing

Apoptosis Proteins and Endothelial Dysfunction in Patients With Atherosclerosis of Peripheral Arteries

Who this might be right for
AtherosclerosisEndothelial Dysfunction
Ryazan State Medical University 250
Post-approval studies (Phase 4)UnknownNCT03313544
What this trial is testing

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Who this might be right for
MelanomaNon-small CellLung Cancer
Assistance Publique Hopitaux De Marseille 50
Testing effectiveness (Phase 2)Ended earlyNCT01088035
What this trial is testing

Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma

Who this might be right for
Ependymoma
Ann & Robert H Lurie Children's Hospital of Chicago 75
Testing effectiveness (Phase 2)UnknownNCT03753243
What this trial is testing

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mark Garzotto, MD 32
Not applicableUnknownNCT05374720
What this trial is testing

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

Who this might be right for
SalpingectomyHysterectomyPrimary Ciliary Dyskinesia+1 more
Centre Hospitalier Intercommunal Creteil 50
Not applicableActive Not RecruitingNCT06172374
What this trial is testing

A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials

Who this might be right for
Primary Ciliary Dyskinesia
ReCode Therapeutics 150
Not applicableActive Not RecruitingNCT03256773
What this trial is testing

High Resolution Micro OCT Imaging

Who this might be right for
Cystic FibrosisCOPDPCD - Primary Ciliary Dyskinesia+2 more
University of Alabama at Birmingham 60
Testing effectiveness (Phase 2)Study completedNCT05535569
What this trial is testing

Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer

Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50
Early research (Phase 1)Study completedNCT00007163
What this trial is testing

Monoclonal Antibody Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Large-scale testing (Phase 3)WithdrawnNCT03881111
What this trial is testing

First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study

Who this might be right for
Esophageal Neoplasms
Merck Sharp & Dohme LLC
Early research (Phase 1)Looking for participantsNCT07161414
What this trial is testing

Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Who this might be right for
Advanced Solid Tumors
AstraZeneca 40
Testing effectiveness (Phase 2)WithdrawnNCT03746249
What this trial is testing

Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Not applicableLooking for participantsNCT07016477
What this trial is testing

Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure

Who this might be right for
Coronary Artery DiseaseAortic Valve StenosisTomography, X-Ray Computed
Semmelweis University 1,000
Testing effectiveness (Phase 2)Study completedNCT03322540
What this trial is testing

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

Who this might be right for
Lung Cancer
Incyte Corporation 154
Not applicableStudy completedNCT00615225
What this trial is testing

Brain Death: Inflammatory Response, Apoptosis, and Endotoxin Tolerance

Who this might be right for
Brain Death
Delafontaine Hospital
Not applicableStudy completedNCT06028607
What this trial is testing

Feasibility of Consumption of Nutritional Supplementation in Primary Ciliary Dyskinesia

Who this might be right for
Primary Ciliary Dyskinesia
University of Leeds 15
Testing effectiveness (Phase 2)WithdrawnNCT03775707
What this trial is testing

Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria

Who this might be right for
Hepatocellular Carcinoma
Shi Ming
Not applicableStudy completedNCT00685516
What this trial is testing

Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 113
Early research (Phase 1)Study completedNCT00791011
What this trial is testing

Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

Who this might be right for
Hodgkin's LymphomaLow Grade LymphomaLymphoma+3 more
Amgen 33
Load More Results